Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Vir Biotechnology, Inc. (VIR)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   8-K10-K8-K10-K10-K10-K10-K
Net income  515.8528.6528.6-298.7-174.7-115.9-69.9
Depreciation and amortization   [+] 5.3 4.43.32.80.4
Stock-based compensation       5.14.8
Deferred taxes   15.2 -0.1 -0.5-10.9
Change in working capital   [+] 150.5 39.613.712.35.1
Other operating activities   -747.2 63.828.02.14.1
Cash from operations   -47.6 -190.9-129.6-94.1-66.4
   
Capital expenditures   [+] 21.8 6.58.9-8.2-2.7
Acquisitions        -27.3
Other cash from investing   -162.6 -16.6-265.1-52.3 
Cash from investing   -140.8 -9.9-256.2-60.4-30.0
   
Issuance of common stock, net     323.2126.4  
Option exercises   13.1 4.11.10.6 
Other cash from financing   113.4 210.3324.025.6271.2
Cash from financing   100.3 529.5449.225.0271.2
   
Free cash flow   -25.8 -184.4-120.7-102.3-69.1
        Per share (diluted)   ($0.19) ($1.55)($3.98)($13.34)($32.12)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy